Abstract
Twenty years after Gramiak & Shah at the University of Rochester reported the echocardiography contrast [1] the uses and applications of contrast echocardiography are still growing. The need for new and more standardized contrast agents with superior reproducibility and capillary transmission capability has been felt for years [2]. Meltzer et al. [3] and Armstrong et al. [4] reported on commercially prepared contrast agents in the early 1980’s. Feinstein et al. [5] introduced the use of ultrasonic energy (sonication) to create smaller microbubbles. Current knowledge and future prospects about mechanisms of the ultrasound contrast effect and the new contrast agents are summarized in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gramiak R, Shah PM (1968): Echocardiography of the aortic root. Invest Radiol 3: 356–366.
Meerbaum S (1986): Promise and status of myocardial contrast-enhanced two-dimensional echocardiography. Delineation of ischemic risk zone and quantitation of myocardial perfusion defects. J Am Coll Cardiol 7: 395–396.
Meltzer RS, Vermeulen HW, Valk N, Verdow R, Lancee CT, Roelandt J (1982): New echocardiographic contrast agents: Transmission through the lungs and myocardial perfusion imaging. J Cardiovasc Ultrason 1: 277–282.
Armstrong WF, Mueller TM, Kinney EL, Tickner EG, Dillon JC, Feigenbaum H (1982): Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography. Circulation 66:166–173.
Feinstein SB, Ten Cate KJ, Zwehl W, Ong K, Maurer G, Tei C, Shah PM, Meerbaum S, Corday E (1984): Two-dimensional contrast echocardiography, I: In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol 3:14–20.
Kremkau FW, Gramiak R, Carstensen EL, Shah PM, Kramer DH (1970): Ultrasonic detection of cavitation at catheter tips. Am J Roentgenol 110:177–183.
Bove AA, Adams DF, Hugh AE, Lynch PR (1968): Cavitation at catheter tips: A possible cause of air embolus. Invest Radiol 3:159–164.
Bove AA, Ziskin MC, Mulchin WL (1969): Ultrasonic detection of in vivo cavitation and pressure effects of high-speed injections through catheters. Invest Radiol 4: 236–240.
Barrera JG, Fulkerson PK, Rittgers SE, Nerem RM (1978): The nature of contrast echo-cardiographic ‘targets’ (abstract). Circulation 58 (suppl): 11–233.
Schuchman H, Feigenbaum H, Dillon JC (1975): Intracavitary echoes in patients with mitral prosthetic valves. J Clin Ultras 3:107–110.
Meltzer RS, Tickner EG, Popp RL (1980): The source of ultrasound contrast effect. J Clin Ultras 8:121–127.
Meltzer RS, Tickner EG, Popp RL (1982): The source of echocardiographic contrast (pp 7–16) in Meltzer RS, Roelandt J (eds): Contrast Echocardiography. The Hague-Boston-Lancaster: Martinus Nijhoff Publishers (DICM 15).
Koenig K, Meltzer RS (1986): Effect of viscosity on the size of microbubbles generated for use as echocardiographic contrast agents. J Cardiovasc Ultrason 5: 3–4.
Sebba F (1971): Microfoams: An unexploited colloid system. J Colloid Interface Sci 35: 643–646.
Yount DE (1983): A model for microbubble fission in surfactant solutions. J Colloid Interface Sci 91: 349–360.
D’Arrigo (1983): Biological surfactants stabilizing natural microbubbles in aqueous media. Advances in Colloid and Interface Science. Amsterdam: Elsevier Science Publishers 19: 253–307.
Bommer WJ, Miller L, Takeda P, Mason DT, DeMaria AN (1981): Contrast echocardiography: Pulmonary transmission and myocardial perfusion imaging using surfactant stabilized microbubbles (abstract). Circulation 65 (suppl IV): IV–303.
Keller MW, Feinstein SB, Briller RA, Powsner SM (1986): Automated production and analysis of echo contrast agents. J Ultrasound Med 5: 493–498.
Yoon RH, Yordan JL (1986): Zeta-potential measurements on microbubbles generated using various surfactants. J Colloid Interface Sci 113:430–438.
Bommer WJ, Mason DT, DeMaria AN (1979): Studies in contrast echocardiography: Development of new agents with superior reproducibility and transmission through the lungs. Circulation 59–60 (suppl II): 11–17.
Meltzer RS, Tickner EG, Popp RL (1980): Why do the lungs clear ultrasonic contrast? Ultrasound in Med &Biol: 263–269.
Meltzer RS, Sartorius OEH, Lancee CT, Serruys PW, Verdouw PD, Essed C, Roelandt J (1981): Transmission of ultrasonic contrast through the lungs. Ultrasound in Med &Biol 7: 377–384.
Meltzer RS, Vermulen HWJ, Valk NK, Verdouw PD, Lancee CT, Roelandt J (1982): New echocardiographic contrast agents: Transmission through the lungs and myocardial perfusion imaging. J Cardiovasc Ultrason 1: 277–282.
Phillips JH, Burch GE, Hellinger R (1961): The use of intracardiac carbon dioxide in the diagnosis of pericardial disease. Am Heart J 61: 748–755.
Oppenheismer MJ, Durant TM, Stauffer HM, Stewart GH, Lynch PR, Barrera F (1956): In vivo visualization of intracardiac structures with gaseous carbon dioxide. Am J Physiol 186: 325–334.
Meltzer RS, Serruys PW, Hugenholtz PG, Roelandt J (1981): Intravenous carbon dioxide as an echocardiographic contrast agent. J Clin Ultrasound 19: 127–131.
Klicpera M, Glogar D, Mayr H, Mohl W, Losert U, Kaindl F (1982): Myocardial perfusion evaluated by contrast echocardiography. Chest 82: 751–755.
Tambe A, McLaughlin WR, Zimmerman HA (1968): Double contrast medium technique for coronary blood flow studies (abstract). Am J Cardiol 21: 117.
Gramiak R (1982): Contrast agents for diagnostic ultrasound (pp 17–24) in Meltzer RS, Roelandt J (eds): Contrast Echocardiography. The Hague: Martinus Nijhoff Publishers (DICM 15).
Wang X, Wand J, Huang Y, Cai C (1979): Contrast echocardiography with hydrogen peroxide, I: Experimental study. Chinese Med J 92: 595–599.
Wang X, Wand J, Hanrong C, Lu C (1979): Contrast echocardiography with hydrogen peroxide, II: Clinical application. Chinese Med J 92:693–702.
Gaffney FA, Lin JC, Peshock RM, Bush L, Buja LM (1983): Hydrogen peroxide contrast echocardiography. Am J Cardiol 52:607–609.
Kemper AJ, O’Boyle JE, Sharma S, Cohen CA, Kloner RA, Khuri SR, Parisi AF (1983): Hydrogen peroxide contrast-enhanced two-dimensional echocardiography: Real-time in vivo delineation of regional myocardial perfusion. Circulation 68: 603–611.
Kemper AJ, O’Boyle BS, Cohen CA, Taylor A, Parisi AF (1984): Hydrogen peroxide contrast echocardiography: Quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. Circulation 70: 309–317.
Finney JW, Jay BE, Race GJ, Urschel HC, Mallams JT, Baila GA (1966): Removal of cholesterol and other lipids from experimental animal and human atheromatous arteries by dilute hydrogen peroxide. Angiology 17: 223–228.
Jiang L, Pu Sy, Yang MZ, Lu YZ, Chen HZ (1984): Left heart contrast echocardiography using a carbon dioxide producing agent (abstract). Circulation 70 (suppl II): II–5.
Carroll BA, Turner RJ, Tickner EG, Boyle DB, Young SW (1980): Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. Invest Radiol 15:260–266.
Armstrong WF, Mueller TM, Kinney EL, Tickner EG, Dillon JC, Feigenbaum H (1982): Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography. Circulation 66:166–173.
Meltzer RS, Klig V, Teichholz LE (1985): Generating precision microbubbles for use as an echocardiographic contrast agent. J Am Coll Cardiol 5: 978–982.
Ernst A, Cikes I, Cistovic F (1984): Polygelin colloid solution as an echocardiographic contrast agent. J Cardiovasc Ultrason 3:143–145.
Santoso T, Roelandt J, Mansyoer H, Abdurahman N, Meltzer RS, Hugenholtz PG (1985): Myocardial perfusion imaging in humans by contrast echocardiography using polygelin colloid solution. J Am Coll Cardiol 6: 612–620.
Bommer WJ, Mason DT, DeMaria AN (1979): Studies in contrast echocardiography: Development of new agents with superior reproducibility and transmission through the lungs. Circulation 60 (suppl II): 11–17.
Smith MD, Kwan OL, Reiser HJ, DeMaria AN (1984): Superior intensity and reproducibility of SHU-454, a new right heart contrast agent. J Am Coll Cardiol 3: 992–998.
Schartl M, Fritzsch T, Friedman W, Lange L (1984): Quantitative myocardial perfusion studies with a new safe echo contrast agent. J Am Coll Cardiol 3: 563 (abstr).
Miszalok V, Fritzsch T, Schartl M (1986): Myocardial perfusion defects in contrast echocardiography: spatial and temporal localization. Ultrasound in Med & Biol 12: 581–586.
Rovai D, Lombardi M, Ferdeghini EM, Marzilli M, Distante A, Taddei L, Benassi A, DeMaria AN, Labbate A (1987): Color-coded functional imaging of myocardial perfusion by contrast echocardiography (abstract). Circulation 76 (suppl IV): IV–504.
Rovai D, Lombardi M, DE Pieri G, Mazzarisi A, Taddei L, Distante A, Benassi A, Labbate A (1988): Accurate flow quantitation by radiofrequency analysis of contrast echo (abstract). Circulation 78 (suppl II): 11–566.
Rovai D, Lombardi M, Ferdeghini EM, Marzilli M, Distante A, Taddei L, Landini L, Benassi A, L’Abbate A (1988): Detection of regional myocardial underperfusion by contrast-echo functional imaging (abstract). J Am Coll Cardiol 11: 76 .
Matsuda M, Kuwako K, Sugishita Y, Ito I, Akatsuka T (1983): Contrast echocardiography of the left heart by intravenous injections of perfluorochemical emulsion. J Cardiography 13:1021–1028.
Valdes-Cruz LM, Sahn DJ (1984): Ultrasonic contrast studies for the detection of cardiac shunts. J Am Coll Cardiol 3: 978–985.
Mattrey RF, Andre MP (1984): Ultrasonic enhancement of myocardial infarction with per-fluorocarbon compounds in dogs. Am J Cardiol 206–210.
Valdes-Cruz LM, Sahn DJ, Horowitz S (1982): Left ventricular opacification by intravenous injection of safe echo contrast agents: Comparative studies in animals and initial human trials (abstract). Circulation 66 (suppl II): 11–28.
Lang R, Borrow KM, Neuman A, Feinstein SB (1985): Echo contrast agents: Effects of sonicated microbubbles and carrier solutions on left ventricular contractility (abstract). Circulation 72 (suppl III): III–227.
Holt G, Reeves W, Rieder M, Daley L, Murthy M, Christensen C (1985): Negative inotropic effects of intracoronary echo-contrast agents (abstract). J Am Coll Cardiol 5: 474.
Kondo S, Tei C, Meerbaum S, Corday E, Shah P (1984): Hyperemic response of intracoronary contrast agents during two-dimensional echographic delineation of regional myocardium. J Am Coll Cardiol 4: 149–156.
Hayward R, Dawson P (1984): Contrast agents and angiocardiography. Br Heart J 52: 361–368.
Hajduczki I, Rajagopalan RE, Meerbaum S, Drury JK, Corday E (1987): Effects of intra-coronary administered echo-contrast agents on epicardial coronary flow, ECG, and global and regional hemodynamics. J Cardiovasc Ultrason 6:85–93.
Moore CA, Smucker MC, Kaul S (1986): Myocardial contrast echocardiography in humans, I: Safety comparison with routine coronary arteriography. J Am Coll Cardiol 8: 1066–1072.
Lang R, Borow KM, Neuman A, Al-Sadir J, Feinstein S (1986): Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility in humans (abstract). J Am Coll Cardiol 7. 189A.
Keller MW, Feinstein SB (1986): Successful transpulmonary contrast echocardiography for quantitation of myocardial perfusion (abstract). Clin Res 34 (2): 313A.
Feinstein SB (1986, 1988): Contrast Agents for Ultrasonic Imaging. US Patent #4, 572, 203, Feb. 25, 1986 and #4, 718,433, Jan. 12,1988.
Keller MW, Glasheen W, Kuldeep T, Gear A, Kaul S (1988): Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: A major advantage in the imaging of regional myocardial perfusion. J Am Coll Cardiol 12: 1039–1047.
Keller MW, Feinstein SB, Watson DD (1987): Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: An experimental evaluation. Am Heart J 114: 570–575.
Reisner SA, Ong LS, Shapiro JR, Lichtenberg GS, Amico AF, Allen MN, Meltzer RS (1988): Efficacy and safety of myocardial perfusion imaging using intracoronary sonicated albumin in humans (abstract). Circulation 78 (suppl II): 11–565.
Feinstein SB, Heidenreich PA, Dick CD, Schneider JM, Pastoret AF, Rubenstein WA, Appelbaum J, Brehm JL, Aronson S, Ellis J, Roizen M (1988): Albunex®: A new intravascular ultrasound contrast agent: preliminary safety and efficacy results (abstract). Circulation 78 (suppl II): 11–565.
Willard GW (1953): Ultrasonically induced cavitation in water: A step by step process. J Acoust Soc Am 25: 669–686.
Reisner SA, Shapiro JR, Schwarz KQ, Meltzer RS (1988): Sonication of echocontrast agents: A standardized and reproducible method. J Cardiovasc Ultrasonography 7: 273–276.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Dordrecht
About this chapter
Cite this chapter
Reisner, S.A., Shapiro, J.R., Amico, A.F., Meltzer, R.S. (1989). Contrast agents for myocardial perfusion studies. In: Meerbaum, S., Meltzer, R.S. (eds) Myocardial Contrast Two-dimensional Echocardiography. Developments in Cardiovascular Medicine, vol 99. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2346-1_3
Download citation
DOI: https://doi.org/10.1007/978-94-009-2346-1_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7556-5
Online ISBN: 978-94-009-2346-1
eBook Packages: Springer Book Archive